Lecture Details - Overview
SOBO Online
Release Date: December 31, 2009|
Expiration Date: September 30, 2010
28 AMA PRA Category 1 Credit(s)™|
Dec 31, 2009 - Sep 30, 2010, Atlanta, GA
At the conclusion of this school, you should be able to:
- Discuss breast carcinogenesis and the impact of germline mutations on patient management
- Explain the clinical utility and limitations of sentinel lymph node biopsy
- Integrate current staging guidelines into clinical decision making regarding local and systemic therapies
- Discuss advances in breast cancer imaging and early detection, including mammography, ultrasound, MRI, and PET scanning
- Integrate prognostic and predictive factors for breast cancer into patient management decisions and assess the optimal means of HER2 and hormone receptor expression analysis
- Assess optimal radiation therapy strategies for treatment of patients with DCIS, early-stage, and locally advanced breast cancer
- Critically analyze the data guiding the choice of adjuvant chemotherapies, endocrine therapies, or targeted agents for patients with low- and high-risk breast cancer and for elderly patients
- Evaluate the evidence guiding treatment recommendations for the management of patients with hormone-dependent and hormone-independent metastatic breast cancer
- Evaluate organ-specific therapeutic interventions for patients with metastatic disease to the CNS and skeleton
- Integrate palliative care strategies into treatment algorithms for metastatic disease
- List novel chemotherapies and targeted agents currently under evaluation for the treatment of advanced and early-stage breast cancer
- Describe current and emerging strategies for ameliorating or eliminating therapy-associated adverse events
- Assess the evidence supporting an emphasis on quality of life and rehabilitation during and after breast cancer treatment
- Refer appropriate patients to promising clinical trials
Overview and Purpose
Over the past decade, an increasing number of oncologists have concentrated their practices on breast cancer. In order to advance patient care, the School of Breast Oncology was developed. This curriculum-based program focuses exclusively on breast cancer clinical management. This intensive 4-day interactive educational course will provide a comprehensive review of the existing data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment. The curriculum will be evidence based, summarizing the existing data for each topic and applying these data to patient cases.
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.
Choose a Participation Option
To claim credit for this activity you must:
- Participate in the Activity
- Claim your Credit Amount & Certificate Type
If you do not wish to claim credit:
You may bypass all CE information, tests and evaluations and go straight to the activity.
You may not request credit after viewing the activity.
I wish to participate in this
activity and claim credit.
I wish to view the activity
without claiming credit.